New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Twinlab Founding Family Member Joins Health Sciences Group Advisory Board

LOS ANGELES, Jul 27, 2005 (BUSINESS WIRE) -- Health Sciences Group, Inc. (HESG), a provider of innovative nutritional products and functional food ingredients derived from natural sources, announced today that Dean Blechman, founding family member of and former Executive Vice President of Sales at Twinlab Corporation, has joined the company's board of advisors. Mr. Blechman signed a two year consulting agreement with Health Sciences Group.

"We are pleased to have someone of Dean's stature and industry experience working with us," commented Fred E. Tannous, co-chairman and Chief Executive Officer of Health Sciences Group. "His extensive experience in building the sales and marketing infrastructure of Twinlab, and making their name one of the most recognized brands in our industry, is a significant asset to us. We look forward to Dean's insight and counsel as we launch new products and expand our presence in the industry."

"I am very excited to be working with Health Sciences Group," said Mr. Blechman. "I believe the company is well-positioned to achieve growth with its line-up of exciting products and look forward to working with Health Sciences to achieve its business goals and objectives."

With over 25 years of experience, Mr. Blechman is a recognized leader in the nutritional product industry. As the former Executive Vice President of Sales at Twinlab, Mr. Blechman was instrumental in growing Twinlab's annual revenues from $5 million in 1979 to over $330 million in 1999.

In addition to a key role in the design, development, launch and distribution of hundreds of Twinlab products, Mr. Blechman formerly served as a Director and Board Member of the National Nutritional Foods Association (NNFA) and, in this role, was actively involved in the passage of the 1994 Dietary Supplement Health and Education Act (DSHEA).

"We are extremely honored to have Dean as part of our team," said Bill Glaser, co-chairman and president of Health Sciences Group. "He is well known in our industry and brings industry experience that can be invaluable to us. We look forward to working with Dean as we build our business into a leading enterprise."

About Health Sciences Group, Inc.

Health Sciences Group identifies, develops and commercializes innovative nutritional products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically-supported, GRAS-certified ingredients under its Swiss Research(TM) and Swiss Diet(TM) brand names. For more information, visit

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.